10. Comparative Analysis Of Bisoprolol Efficacy In Patients With Normal And Altered Cardiac Anatomy In The Postoperative Period After Catheter Ablation Of Atrial Fibrillation

Авторлар

DOI:

https://doi.org/10.35805/BSK2025III0010

Жүктеулер

Аңдатпа

Background. The aim of this study was to evaluate the effectiveness of the β-adrenergic blocker bisoprolol in maintaining sinus rhythm in patients with atrial fibrillation following catheter ablation of the pulmonary vein ostia, considering the anatomical condition of the left atrium.

Material and methods. A total of 50 patients were enrolled and divided into two groups: those with normal left atrial anatomy (n = 25) and those with pathologically altered anatomy (n = 25). All patients received bisoprolol at a dose of 10 mg/day for 12 months post-ablation.

Results. Within the first 6 months of follow-up, no atrial fibrillation recurrences were observed in the group with normal left atrium anatomy (100%), whereas 92% of patients in the altered anatomy group experienced recurrences. In the second half of the follow-up period (months 6–12), differences between the groups were no longer statistically significant. Statistical analysis confirmed a highly significant difference in recurrence rates during the early postoperative period (p < 0.001) and no significant difference in the late period (p > 0.3).

Conclusion. The effectiveness of bisoprolol in maintaining sinus rhythm is highly dependent on the anatomical condition of the left atrium in the early period following ablation. The results highlight the importance of individualizing antiarrhythmic therapy based on morphofunctional characteristics.

Кілт сөздер

left atrial anatomy, β-adrenergic blockers, bisoprolol, catheter ablation, atrial fibrillation

Әдебиеттер тізімі

  1. Alobaida M, Alrumayh A. Rate control strategies for atrial fibrillation. Ann Med. Dec 2021;53(1):682-692. doi:10.1080/07853890.2021.1930137
  2. Kirchhof P, Breithardt G, Bax J, et al. A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. Europace. Jan 2016;18(1):37-50. doi:10.1093/europace/euv304
  3. Yamamoto T, Endo D, Matsushita S, et al. Evidence and Challenges in Left Atrial Appendage Management. Ann Thorac Cardiovasc Surg. Feb 20 2022;28(1):1-17. doi:10.5761/atcs.ra.21-00040
  4. Suzuki Y, Kuroda M, Fujioka T, et al. Impact of bisoprolol transdermal patch on early recurrence during the blanking period after atrial fibrillation ablation. J Arrhythm. Jun 2021;37(3):607-615. doi:10.1002/joa3.12538
  5. Babic M, Djurdjevic B, Vukajlovic D, et al. Catheter Ablation of Atrial Tachycardia after Pulmonary Vein Isolation in a Patient with Common Ostium of Inferior Pulmonary Veins: Case Report. Medicina (Kaunas). Feb 2 2024;60(2). doi:10.3390/medicina60020264
  6. Muresan L, Cismaru G, Muresan C, et al. Beta-blockers for the treatment of arrhythmias: Bisoprolol - a systematic review. Ann Pharm Fr. Sep 2022;80(5):617-634. doi:10.1016/j.pharma.2022.01.007
  7. Baimbetov AK, Bizhanov KA, Jukenova AM, Aubakirova AT, Ualiyeva AY, Sagatov IY. Comparative Effectiveness and Safety of Cryoablation Versus Radiofrequency Ablation Treatments for Persistent Atrial Fibrillation. Am J Cardiol. Dec 1 2022;184:22-30. doi:10.1016/j.amjcard.2022.08.031
  8. Baimbetov A, Bizhanov K, Yakupova I, et al. Efficacy and Safety Results of Different Ablation Technologies for Persistent Atrial Fibrillation Treatment. Heart Surg Forum. Aug 21 2022;25(4):E594-E600. doi:10.1532/hsf.4853
  9. Gerach T, Schuler S, Wachter A, Loewe A. The Impact of Standard Ablation Strategies for Atrial Fibrillation on Cardiovascular Performance in a Four-Chamber Heart Model. Cardiovasc Eng Technol. Apr 2023;14(2):296-314. doi:10.1007/s13239-022-00651-1
  10. Baram A, Safran M, Noy T, Geri N, Greenspan H. Neural network reconstruction of the left atrium using sparse catheter paths. Int J Comput Assist Radiol Surg. Feb 2025;20(2):405-414. doi:10.1007/s11548-024-03268-y
  11. Abouzid MR, Vyas A, Eldahtoury S, et al. Which should you choose for post operative atrial fibrillation, carvedilol or metoprolol? A systematic review and meta-analysis. Curr Probl Cardiol. Feb 2024;49(2):102220. doi:10.1016/j.cpcardiol.2023.102220
  12. Wu PH, Lin YT, Liu JS, et al. Comparative effectiveness of bisoprolol and carvedilol among patients receiving maintenance hemodialysis. Clin Kidney J. Mar 2021;14(3):983-990. doi:10.1093/ckj/sfaa248
  13. Kisheva A, Yotov Y. Risk factors for recurrence of atrial fibrillation. Anatol J Cardiol. May 2021;25(5):338-345. doi:10.14744/AnatolJCardiol.2020.80914

Жарияланды

2025-09-30

Журналдың саны

Бөлім

Статьи